Vanguard Group’s BAXANO SURGICAL INC COM STK (DE) BAXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-719,950
Closed -$132K 4067
2014
Q3
$132K Buy
719,950
+107,834
+18% +$44.1K ﹤0.01% 3933
2014
Q2
$349K Hold
612,116
﹤0.01% 3757
2014
Q1
$661K Buy
612,116
+218,852
+56% +$275K ﹤0.01% 3574
2013
Q4
$397K Buy
393,264
+6,700
+2% +$7.76K ﹤0.01% 3639
2013
Q3
$537K Buy
386,564
+31,200
+9% +$57.9K ﹤0.01% 3534
2013
Q2
$853K Buy
+355,364
New +$797K ﹤0.01% 3347

Other funds holding BAXS

Vanguard Group's BAXS Position: Q4 2014 in Review

Vanguard Group sold out of BAXANO SURGICAL INC COM STK (DE) (BAXS) in Q4 2014, closing a stake of 719,950 shares — an estimated $132K sold.

Vanguard Group first reported a position in BAXS in Q2 2013 and held it in 6 quarters. The position peaked at $853K in Q2 2013. 6 funds tracked by Wall St. Rank hold BAXS as of Q4 2014.

  • Vanguard Group reported no remaining BAXANO SURGICAL INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Vanguard Group sold 719,950 BAXANO SURGICAL INC COM STK (DE) shares in Q4 2014, an estimated $132K.
  • Vanguard Group first reported a position in BAXANO SURGICAL INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
  • Vanguard Group's BAXANO SURGICAL INC COM STK (DE) position peaked at $853K in Q2 2013.
  • 6 funds tracked by Wall St. Rank held BAXANO SURGICAL INC COM STK (DE) as of Q4 2014.

Based on Vanguard Group's 13F filing for Q4 2014, filed 12 Feb 2015.